Theseus Pharmaceuticals - Delisted Stock
Theseus Pharmaceuticals is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day Theseus Pharmaceuticals was actively traded.
Valuation
Check how we calculate scores
Theseus Pharmaceuticals Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Theseus Pharmaceuticals market risk premium is the additional return an investor will receive from holding Theseus Pharmaceuticals long position in a well-diversified portfolio.
Mean Deviation | 5.44 | |||
Standard Deviation | 10.73 | |||
Variance | 115.1 | |||
Risk Adjusted Performance | (0.03) |
View Theseus Pharmaceuticals Related Equities
Risk & Return | Correlation |
Theseus Pharmaceuticals Corporate Management
DPhil DPHIL | CoFounder Chairman | Profile | |
Timothy Clackson | Pres CEO | Profile | |
Len Rozamus | VP Operations | Profile | |
Nachu Narasimhan | VP Safety | Profile | |
Bradford Dahms | Chief officer | Profile | |
WeiSheng Huang | CoFounder Chemistry | Profile | |
Alicja Januszewicz | VP Culture | Profile |
Still Interested in Theseus Pharmaceuticals?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Theseus Stock
If you are still planning to invest in Theseus Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Theseus Pharmaceuticals' history and understand the potential risks before investing.
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Stocks Directory Find actively traded stocks across global markets | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |